Close
ACHEMA MIDDLE EAST 2026

5 COVID Therapies Are Not Cost-Effective, According To NICE

Five COVID-19 therapies, including Merck & Co.'s antiviral tablet for high-risk patients, have been recommended for discontinuation by Britain's agency that decides whether medications...

IGBA Claims That 2022 WHO Biosimilar Guideline Boosts Access

According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic and Biosimilar Medicines Association...

GHIT Fund Invests ¥790M In Ignored Tropical Disease Products

Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the Global Health Innovative Technology...

To Reach Emission Goals, Seven Pharma CEOs Band Together

Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have launched a collaborative effort to meet short-term emission reduction...

Sustainable Pharmaceutical Packaging: Removing Barriers

The majority of consumers base their first impression of a business and its sustainability credentials on the product packaging. With a third of UK consumers...

OSD Contract Manufacturing To Hit $54.7 Billion by 2030

According to a market analysis, the global oral solid dosage (OSD) contract manufacturing market is forecast to grow $54.7 billion in value by 2030,...

Pharma In Africa Needs Indigenous Emphasis And Investment

The growth of the domestic pharmaceutical industry and a reduction in reliance on imports might be facilitated by funding AI-based research and development and...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...